A 2025 Cureus study followed 52 men treated with water vapor thermal therapy for BPH.
A 2025 Cureus study followed 52 men treated with water vapor thermal therapy for BPH.
A 2025 Cureus study followed 52 men treated with water vapor thermal therapy for BPH. Results showed major improvements in urinary symptoms and flow rates, with low complication rates—an encouraging minimally invasive option for older adults.
Use the full description to understand the study design, methods, and the limits of the findings.
This research reports one-year outcomes of water vapor thermal therapy (Rezum) for benign prostatic hyperplasia. The study tracks urinary symptom improvement, quality of life, sexual function preservation, and retreatment rates following this minimally invasive procedure.
Open the original publication for the complete methods, outcomes, and source material.
The study provides valuable insights into the use of water vapor thermal therapy for BPH, showing promising results. However, limitations in study design, sample size, and lack of detailed statistical methodology reduce the overall quality. The study is transparent in conflict disclosures but lacks replication efforts.
| Category | Score | Rating |
|---|---|---|
| Study Design / Evidence Level | 6.7/10 | |
| Bias & Methods | 5.0/10 | |
| Statistical Integrity | 7.5/10 | |
| Transparency | 5.0/10 | |
| Conflict of Interest Disclosure | 10.0/10 | |
| Replication / External Validation | 5.0/10 | |
| Relevance to Seniors | 10.0/10 | |
| Journal Quality | 5.0/10 |
Future studies should aim for larger sample sizes, include randomization and blinding, and provide detailed statistical methodologies to enhance the robustness of findings.
These condition pages help connect the paper back to the real-world health concerns it addresses.
Build a personalized plan using research-backed studies, conditions, and treatments.